Antimicrobial Susceptibility-Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance (Q41224420)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 May 2015

Language	Label	Description	Also known as
English	Antimicrobial Susceptibility-Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance	scientific article published on 15 May 2015

Statements

scholarly article

1 reference

Europe PubMed Central

28 September 2017

Antimicrobial Susceptibility-Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance (English)

1 reference

Europe PubMed Central

28 September 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25982426%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Angel Cosme

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25982426%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Jacobo Lizasoan

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25982426%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Milagrosa Montes

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25982426%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Esther Tamayo

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25982426%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Horacio Alonso

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25982426%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Usua Mendarte

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25982426%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Maider Martos

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25982426%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

María Fernández-Reyes

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25982426%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Cristina Saraqueta

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25982426%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

15 May 2015

1 reference

Europe PubMed Central

28 September 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25982426%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25982426%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25982426%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

29-34

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25982426%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12231

21 January 2018

Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12231

21 January 2018

Helicobacter pylori treatment in the era of increasing antibiotic resistance

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12231

21 January 2018

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12231

21 January 2018

Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12231

21 January 2018

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12231

21 January 2018

Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12231

21 January 2018

Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12231

21 January 2018

Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12231

21 January 2018

Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12231

21 January 2018

Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12231

21 January 2018

Is antimicrobial susceptibility testing necessary before first-line treatment for Helicobacter pylori infection? Meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12231

21 January 2018

Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12231

21 January 2018

Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12231

21 January 2018

Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12231

21 January 2018

Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12231

21 January 2018

Identifiers

10.1111/HEL.12231

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25982426%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25982426%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41224420&oldid=2094390474"